Rare diseases
Investigational molecules
Locations
Calle La Maso 38, 28035 Madrid, Spain
Hospital Ruber Internacional in Madrid, Spain specialises in clinical trials of conditions such as Partial seizures, Severe myoclonic epilepsy of infancy, Epileptic encephalopathy, Lennox-Gastaut syndrome, and other specialisations. This site conducts important research.
Hospital Ruber Internacional’s neurology team is advancing the treatment of epilepsy and related encephalopathies through studies that assess safety and seizure‑reduction potential of emerging medicines.
The goal is to improve seizure control and quality of life for patients with rare and treatment‑resistant seizure disorders.
In the oncology unit, investigators are evaluating a biosimilar to Opdivo for patients with advanced melanoma, focusing on comparable efficacy and safety.
These trials aim to broaden access to effective immunotherapy options while maintaining clinical outcomes.
The department conducts research on prostate cancer to determine the optimal duration of androgen deprivation therapy combined with salvage radiotherapy after surgical recurrence.
Findings are expected to refine treatment protocols and improve long‑term disease‑free survival.
Studies at the site explore disease‑modifying strategies for Early Parkinson’s Disease, measuring impact on functional scores such as the MDS‑UPDRS.
The research seeks to delay progression and maintain daily living abilities for individuals newly diagnosed with Parkinson’s.
A dedicated program investigates therapies for congenital, hereditary and neonatal neurological conditions, targeting specific genetic mutations that drive severe seizure phenotypes.
By focusing on precision medicine, the trials aim to deliver targeted treatments that address the underlying genetic causes.
Clinical trials currently enrolling participants at this site.
Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
SpainA Study Comparing MB11 and Nivolumab in Adults With Previously Untreated Advanced or Metastatic Melanoma
SpainStudy of intrathecal S230815 to evaluate safety and effectiveness in children with KCNT1-related Developmental and Epileptic Encephalopathy
SpainStudy on the Safety and Effectiveness of Bexicaserin for Seizures in Children and Adults with Developmental and Epileptic Encephalopathy
SpainStudy on the Effects of Full Spectrum Cannabis Extract (Dronabinol, Cannabidiol) for Patients with Hard-to-Treat Epilepsy in Tuberous Sclerosis Complex
SpainStudy on the Safety and Effectiveness of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older
SpainComparison of Short vs Long-term Hormone Therapy with Goserelin, Leuprorelin, or Triptorelin Combined with Radiation for Prostate Cancer Patients After Surgery
SpainStudy on the Safety of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older
SpainStudy on Carisbamate for Treating Seizures in Children and Adults with Lennox-Gastaut Syndrome
SpainStudy on the Long-term Safety and Tolerability of Azetukalner for Patients with Epilepsy, Including Focal-onset and Primary Generalized Tonic-Clonic Seizures
SpainA study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease
SpainSafety and Tolerability of Intrathecal ION337 in Patients with Dravet Syndrome
SpainMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
